MoonLake Immunotherapeutics Cash Flow Reinvestment Rate
Latest as of June 2021:
2.61x
MoonLake Immunotherapeutics cash flow reinvestment rate. MoonLake Immunotherapeutics (MLTX) has a Cash Flow Reinvestment Rate of 2.61x as of June 2021, reinvesting $16.01K (capex $16.01K ) from operating cash flow of $6.14K. Explore debt repayment capacity of MoonLake Immunotherapeutics to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
2.61x
(Capex + Investments) / Operating CF
Total Reinvested
$16.01K
Capex + Investments
Operating Cash Flow
$6.14K
USD
Capital Expenditures
$16.01K
USD
MoonLake Immunotherapeutics Cash Flow Reinvestment Rate by Year (None–None)
MoonLake Immunotherapeutics cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for MoonLake Immunotherapeutics. For the full cash flow conversion analysis, see cash flow conversion of MoonLake Immunotherapeutics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow